mTOR-regulated U2af1 tandem exon splicing specifies transcriptome features for translational control

被引:9
|
作者
Chang, Jae-Woong [1 ]
Yeh, Hsin-Sung [1 ]
Park, Meeyeon [1 ]
Erber, Luke [1 ]
Sun, Jiao [2 ]
Cheng, Sze [1 ]
Bui, Alexander M. [1 ]
Fahmi, Naima Ahmed [2 ]
Nasti, Ryan [3 ]
Kuang, Rui [4 ]
Chen, Yue [1 ]
Zhang, Wei [2 ]
Yong, Jeongsik [1 ]
机构
[1] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA
[2] Univ Cent Florida, Dept Comp Sci, Orlando, FL 32816 USA
[3] Univ Minnesota Twin Cities, Dept Genet Cell & Dev Biol, Minneapolis, MN 55455 USA
[4] Univ Minnesota Twin Cities, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
PRE-MESSENGER-RNA; IN-VIVO; SITE RECOGNITION; FACTOR U2AF(35); REVEALS; COMPLEX; PROTEIN; IDENTIFICATION; REQUIREMENT; MUTATIONS;
D O I
10.1093/nar/gkz761
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
U2 auxiliary factor 1 (U2AF1) functions in 3'-splice site selection during pre-mRNA processing. Alternative usage of duplicated tandem exons in U2AF1 produces two isoforms, U2AF1a and U2AF1b, but their functional differences are unappreciated due to their homology. Through integrative approaches of genome editing, customized-transcriptome profiling and crosslinking-mediated interactome analyses, we discovered that the expression of U2AF1 isoforms is controlled by mTOR and they exhibit a distinctive molecular profile for the splice site and protein interactomes. Mechanistic dissection of mutually exclusive alternative splicing events revealed that U2AF1 isoforms' inherent differential preferences of nucleotide sequences and their stoichiometry determine the 3'-splice site. Importantly, U2AF1a-driven transcriptomes feature alternative splicing events in the 5'-untranslated region (5'-UTR) that are favorable for translation. These findings unveil distinct roles of duplicated tandem exon-derived U2AF1 isoforms in the regulation of the transcriptome and suggest U2AF1a-driven 5'-UTR alternative splicing as a molecular mechanism of mTOR-regulated translational control.
引用
收藏
页码:10373 / 10387
页数:15
相关论文
共 13 条
  • [1] Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
    Graubert, Timothy A.
    Shen, Dong
    Ding, Li
    Okeyo-Owuor, Theresa
    Lunn, Cara L.
    Shao, Jin
    Krysiak, Kilannin
    Harris, Christopher C.
    Koboldt, Daniel C.
    Larson, David E.
    McLellan, Michael D.
    Dooling, David J.
    Abbott, Rachel M.
    Fulton, Robert S.
    Schmidt, Heather
    Kalicki-Veizer, Joelle
    O'Laughlin, Michelle
    Grillot, Marcus
    Baty, Jack
    Heath, Sharon
    Frater, John L.
    Nasim, Talat
    Link, Daniel C.
    Tomasson, Michael H.
    Westervelt, Peter
    DiPersio, John F.
    Mardis, Elaine R.
    Ley, Timothy J.
    Wilson, Richard K.
    Walter, Matthew J.
    NATURE GENETICS, 2012, 44 (01) : 53 - U77
  • [2] Alternative splicing of U2AF1 reveals a shared repression mechanism for duplicated exons
    Kralovicova, Jana
    Vorechovsky, Igor
    NUCLEIC ACIDS RESEARCH, 2017, 45 (01) : 417 - 434
  • [3] A Pan-Cancer Analysis of Transcriptome Changes Associated with Somatic Mutations in U2AF1 Reveals Commonly Altered Splicing Events
    Brooks, Angela N.
    Choi, Peter S.
    de Waal, Luc
    Sharifnia, Tanaz
    Imielinski, Marcin
    Saksena, Gordon
    Pedamallu, Chandra Sekhar
    Sivachenko, Andrey
    Rosenberg, Mara
    Chmielecki, Juliann
    Lawrence, Michael S.
    DeLuca, David S.
    Getz, Gad
    Meyerson, Matthew
    PLOS ONE, 2014, 9 (01):
  • [4] U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing
    Okeyo-Owuor, T.
    White, B. S.
    Chatrikhi, R.
    Mohan, D. R.
    Kim, S.
    Griffith, M.
    Ding, L.
    Ketkar-Kulkarni, S.
    Hundal, J.
    Laird, K. M.
    Kielkopf, C. L.
    Ley, T. J.
    Walter, M. J.
    Graubert, T. A.
    LEUKEMIA, 2015, 29 (04) : 909 - 917
  • [5] Wild-Type U2AF1 Antagonizes the Splicing Program Characteristic of U2AF1-Mutant Tumors and Is Required for Cell Survival
    Fei, Dennis Liang
    Motowski, Hayley
    Chatrikhi, Rakesh
    Prasad, Sameer
    Yu, Jovian
    Gao, Shaojian
    Kielkopf, Clara L.
    Bradley, Robert K.
    Varmus, Harold
    PLOS GENETICS, 2016, 12 (10):
  • [6] The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation
    Palangat, Murali
    Anastasakis, Dimitrios G.
    Fei, Dennis Liang
    Lindblad, Katherine E.
    Bradley, Robert
    Hourigan, Christopher S.
    Hafner, Markus
    Larson, Daniel R.
    GENES & DEVELOPMENT, 2019, 33 (9-10) : 482 - 497
  • [7] U2AF1 mutation connects DNA damage to the alternative splicing of RAD51 in lung adenocarcinomas
    Chen, Chuanhui
    Zhou, Pinglang
    Zhang, Zhizhe
    Liu, Yu
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2022, 49 (07) : 740 - 747
  • [8] Deoxynivalenol globally affects the selection of 3' splice sites in human cells by suppressing the splicing factors, U2AF1 and SF1
    Hu, Zhangsheng
    Sun, Yu
    Chen, Jiongjie
    Zhao, Yurong
    Qiao, Han
    Chen, Ruohong
    Wen, Xianhui
    Deng, Yiqun
    Wen, Jikai
    RNA BIOLOGY, 2020, 17 (04) : 584 - 595
  • [9] Promoter R-Loops Recruit U2AF1 to Modulate Its Phase Separation and RNA Splicing
    He, Xiaomei
    Yuan, Jun
    Gao, Zi
    Wang, Yinsheng
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2023, 145 (39) : 21646 - 21660
  • [10] Aberrant Alternative Splicing in U2af1/Tet2 Double Mutant Mice Contributes to Major Hematological Phenotypes
    Martinez-Valiente, Cristina
    Garcia-Ruiz, Cristian
    Roson, Beatriz
    Liquori, Alessandro
    Gonzalez-Romero, Elisa
    Fernandez-Gonzalez, Raul
    Gomez-Redondo, Isabel
    Cervera, Jose
    Gutierrez-Adan, Alfonso
    Sanjuan-Pla, Alejandra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)